Search results for " mRNA vaccines" in Articles / App Notes
Article
mRNA Therapeutics and Vaccines – Key Process Considerations
Click here >>
Learn more on key considerations and strategies for process development and scaling up in our new web hub for mRNA therapeutics and vaccines.
Article
mRNA vaccines: current trends and perspectives
The promise and challenges of mRNA vaccine development.
READ MORE >>
Article
mRNA Vaccines: Current Trends and Perspectives
Read more >>
mRNA therapy is a rapidly growing field. The technology offers great benefit and potential for infectious diseases and personalized medicines due to its advantages in flexibility, co…
Article
mRNA Processing Workflow for Vaccines and Therapeutics
CLICK HERE TO VIEW >>
Learn more on key considerations when setting up a messenger RNA (mRNA) process with this infographic.
Article
Process Development challenges for mRNA vaccines and beyond
Key insights from industry experts on the future of therapeutic mRNA manufacturing.
READ MORE >>
Article
Increasing mRNA Capabilities and Capacity for Growing Market Needs
Click here to read more >>
The success of the mRNA vaccine market is fueling high demand for mRNA, resulting in a critical need to address the manufacturing bottlenecks.
Article
Reducing the Risk of RNAse Contamination in mRNA Production
As drug and vaccine manufacturers work to optimize mRNA production processes, one hurdle to overcome is mRNA’s susceptibility to breakdown by ribonuclease (RNase) enzymes introduced during p…
Article
Discussing the Origins of the mRNA Therapeutics Field
Andy Geall, co-founder and chief development officer at Replicate Bioscience, discusses the historical context and buildup of the mRNA therapeutics field.
Watch video
Article
mRNA Global Alliance Tests the Waters at BIO
World leaders have set ambitious goals to respond more swiftly to the next pandemic, including the US goal to design, test, and review a new vaccine just 100 days after a pandemic declaration.…
Article
Analysis of mRNA Therapeutics and Vaccines
Analytical approaches must keep pace to ensure the identity, safety, and efficacy of evolving mRNA candidates.
Read more here >>>